The old and new therapeutic approaches to the treatment of giardiasis: Where are we?

Review

(3373) Views  (1055) Full article downloads

Authors: Haendel GNO Busatti, Joseph FG Santos, Maria A Gomes

Published Date June 2009 Volume 2009:3 Pages 273 - 287

DOI: http://dx.doi.org/10.2147/BTT.S3943

Haendel GNO Busatti¹, Joseph FG Santos², Maria A Gomes¹

¹Departmento de Parasitologia, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil; ²Hospital Santa Casa de Misericórdia de Belo Horizonte, Minas Gerais, Brasil

Abstract: Giardia lamblia is the causative agent of giardiasis, one of the most common parasitic infections of the human intestinal tract. This disease most frequently affects children causing abdominal pain, nausea, vomiting, acute or chronic diarrhea, and malabsorption syndrome. In undernourished children, giardiasis is a determining factor in retarded physical and mental development. Antigiardial chemotherapy focuses on the trophozoite stage. Metronidazole and other nitroimidazoles have been used for decades as the therapy of choice against giardiasis. In recent years many other drugs have been proposed for the treatment of giardiasis. Therefore, several synthetic and natural substances have been tested in search of new giardicidal compounds. This study is a review of drugs used in in vitro and in vivo tests, and also drugs tested in clinical trials (nonrandomized and randomized).

Keywords: Giardia lamblia; treatment; new drugs